Position in KURA
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$956,852
+$651,680 QoQ
Shares Held
117,694
+454.6% QoQ
Ownership
0.133%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2023
5 quarters on record
Voting authority
Sole 78.24867877716791.ToString("F0")%
Shared 0.ToString("F0")%
None 21.75132122283209.ToString("F0")%
Common Shares in KURA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MARTINGALE ASSET MANAGEMENT L P holds $113,335,067 across 56 Biotechnology names. KURA ranks #26 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
44,750 | $19,982,665 | |
| 2 | INCY |
Incyte Corp
|
164,646 | $15,496,481 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
16,861 | $13,027,483 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
46,721 | $8,832,605 | |
| 5 | LGND |
Ligand Pharmaceuticals Inc
|
17,762 | $3,546,183 | |
| 6 | CPRX |
Catalyst Pharmaceuticals, Inc.
|
139,535 | $3,454,886 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
10,114 | $3,346,419 | |
| 8 | ACAD |
Acadia Pharmaceuticals Inc
|
139,964 | $3,115,598 |
All Filings in KURA
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $956,852 | 117,694 | Shares | Sole | 2026-05-13 | |
| 2023-12-31 | $305,172 | 21,222 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $193,544 | 21,222 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $699,909 | 66,154 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $522,453 | 42,719 | Shares | Sole | 2023-05-12 | |
| No filing history on record for this holder in this stock. | ||||||